Sulfotransferase SULT1A1 Arg213His Polymorphism with Cancer Risk: A Meta-Analysis of 53 Case-Control Studies

被引:12
作者
Xiao, Juanjuan [1 ]
Zheng, Yabiao [1 ]
Zhou, Yinghui [1 ]
Zhang, Ping [1 ]
Wang, Jianguo [1 ]
Shen, Fangyuan [1 ]
Fan, Lixia [1 ]
Kolluri, Vijay Kumar [1 ]
Wang, Weiping [1 ]
Yan, Xiaolong [2 ]
Wang, Minghua [1 ]
机构
[1] Soochow Univ, Coll Med, Dept Biochem & Mol Biol, Suzhou, Jiangsu, Peoples R China
[2] Fourth Mil Med Univ, Tangdu Hosp, Dept Thorac Surg, Xian 710032, Shaanxi, Peoples R China
来源
PLOS ONE | 2014年 / 9卷 / 09期
基金
中国国家自然科学基金;
关键词
CARCINOGEN-METABOLIZING ENZYMES; BREAST-CANCER; GENETIC POLYMORPHISMS; PROSTATE-CANCER; LUNG-CANCER; ARG(213)HIS POLYMORPHISM; PHENOL SULFOTRANSFERASES; COLORECTAL-CANCER; 1A1; POLYMORPHISM; BLADDER-CANCER;
D O I
10.1371/journal.pone.0106774
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: The SULT1A1 Arg213His (rs9282861) polymorphism is reported to be associated with many kinds of cancer risk. However, the findings are conflicting. For better understanding this SNP site and cancer risk, we summarized available data and performed this meta-analysis. Methods: Data were collected from the following electronic databases: PubMed, Web of Knowledge and CNKI. The association was assessed by odd ratio (OR) and the corresponding 95% confidence interval (95% CI). Results: A total of 53 studies including 16733 cancer patients and 23334 controls based on the search criteria were analyzed. Overall, we found SULT1A1 Arg213His polymorphism can increase cancer risk under heterozygous (OR = 1.09, 95% CI = 1.01-1.18, P = 0.040), dominant (OR = 1.10, 95% CI = 1.01-1.19, P = 0.021) and allelic (OR = 1.08, 95% CI = 1.02-1.16, P = 0.015) models. In subgroup analyses, significant associations were observed in upper aero digestive tract (UADT) cancer (heterozygous model: OR = 1.62, 95% CI = 1.11-2.35, P = 0.012; dominant model: OR = 1.63, 95% CI = 1.13-2.35, P = 0.009; allelic model: OR = 1.52, 95% CI = 1.10-2.11, P = 0.012) and Indians (recessive model: OR = 1.93, 95% CI = 1.22-3.07, P = 0.005) subgroups. Hospital based study also showed marginally significant association. In the breast cancer subgroup, ethnicity and publication year revealed by meta-regression analysis and one study found by sensitivity analysis were the main sources of heterogeneity. The association between SULT1A1 Arg213His and breast cancer risk was not significant. No publication bias was detected. Conclusions: The present meta-analysis suggests that SULT1A1 Arg213His polymorphism plays an important role in carcinogenesis, which may be a genetic factor affecting individual susceptibility to UADT cancer. SULT1A1 Arg213His didn't show any association with breast cancer, but the possible risk in Asian population needs further investigation.
引用
收藏
页数:11
相关论文
共 64 条
  • [1] [Anonymous], CHINESE J DIS CONTRO
  • [2] Sulfotransferase 1A1 Arg213His polymorphism and prostate cancer risk
    Arslan, Serdal
    Silig, Yavuz
    Pinarbasi, Hatice
    [J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2011, 2 (06) : 1159 - 1162
  • [3] An investigation of the relationship between SULT1A1 Arg213His polymorphism and lung cancer susceptibility in a Turkish population
    Arslan, Serdal
    Silig, Yavuz
    Pinarbasi, Hatice
    [J]. CELL BIOCHEMISTRY AND FUNCTION, 2009, 27 (04) : 211 - 215
  • [4] Phenol sulphotransferase SULT1A1*1 genotype is associated with reduced risk of colorectal cancer
    Bamber, DE
    Fryer, AA
    Strange, RC
    Elder, JB
    Deakin, M
    Rajagopal, R
    Fawole, A
    Gilissen, RAHJ
    Campbell, FC
    Coughtrie, MWH
    [J]. PHARMACOGENETICS, 2001, 11 (08): : 679 - 685
  • [5] Polymorphisms in metabolic genes, their combination and interaction with tobacco smoke and alcohol consumption and risk of gastric cancer: a case-control study in an Italian population
    Boccia, Stefania
    Sayed-Tabatabaei, Fakhredin A.
    Persiani, Roberto
    Gianfagna, Francesco
    Rausei, Stefano
    Arzani, Dario
    La Greca, Antonio
    D'Ugo, Domenico
    La Torre, Giuseppe
    van Duijn, Cornelia M.
    Ricciardi, Gualtiero
    [J]. BMC CANCER, 2007, 7 (1)
  • [6] A case-control study investigating the role of sulfotransferase 1A1 polymorphism in head and neck cancer
    Boccia, Stefania
    Cadoni, Gabriella
    La Torre, Giuseppe
    Arzani, Dario
    Volante, Mariangela
    Cattel, Caterina
    Gianfagna, Francesco
    Paludetti, Gaetano
    Almadori, Giovanni
    Ricciardi, Gualtiero
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2006, 132 (07) : 466 - 472
  • [7] CYP17 & SULT1A1 gene polymorphisms in Indian breast cancer
    Chacko P.
    Rajan B.
    Mathew B.S.
    Joseph T.
    Pillai M.R.
    [J]. Breast Cancer, 2004, 11 (4) : 380 - 388
  • [8] Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women
    Chang-Claude, Jenny
    Beckmann, Lars
    Corson, Charlotte
    Hein, Rebecca
    Kropp, Silke
    Parthimos, Margie
    Duennebier, Thomas
    Hamann, Ute
    Brors, Benedikt
    Eils, Roland
    Zapatka, Marc
    Brauch, Hiltrud
    Justenhoven, Christina
    Flesch-Janys, Dieter
    Braendle, Wilhelm
    Bruening, Thomas
    Pesch, Beate
    Spickenheuer, Anne
    Ko, Yon-Dschun
    Baisch, Christian
    Dahmen, Norbert
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2010, 119 (02) : 463 - 474
  • [9] Chen Kun, 2006, Zhonghua Zhongliu Zazhi, V28, P670
  • [10] Breast cancer risk associated with genotype polymorphism of the catechol estrogen-metabolizing genes: A multigenic study on cancer susceptibility
    Cheng, TC
    Chen, ST
    Huang, CS
    Fu, YP
    Yu, JC
    Cheng, CW
    Wu, PE
    Shen, CY
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2005, 113 (03) : 345 - 353